Specific Follicular Helper T Cell Signature in Takayasu Arteritis

Arthritis Rheumatol. 2021 Jul;73(7):1233-1243. doi: 10.1002/art.41672. Epub 2021 May 19.

Abstract

Objective: Our aim was to compare transcriptome and phenotype profiles of CD4+ T cells and CD19+ B cells in patients with Takayasu arteritis (TAK), patients with giant cell arteritis (GCA), and healthy donors.

Methods: Gene expression analyses, flow cytometry immunophenotyping, T cell receptor (TCR) gene sequencing, and functional assessments of cells from peripheral blood and arterial lesions from TAK patients, GCA patients, and healthy donors were performed.

Results: Among the most significantly dysregulated genes in CD4+ T cells of TAK patients compared to GCA patients (n = 720 genes) and in CD4+ T cells of TAK patients compared to healthy donors (n = 1,447 genes), we identified a follicular helper T (Tfh) cell signature, which included CXCR5, CCR6, and CCL20 genes, that was transcriptionally up-regulated in TAK patients. Phenotypically, there was an increase in CD4+CXCR5+CCR6+CXCR3- Tfh17 cells in TAK patients that was associated with a significant enrichment of CD19+ B cell activation. Functionally, Tfh cells helped B cells to proliferate, differentiate into memory cells, and secrete IgG antibodies. Maturation of B cells was inhibited by JAK inhibitors. Locally, in areas of arterial inflammation, we found a higher proportion of tertiary lymphoid structures comprised CD4+, CXCR5+, programmed death 1+, and CD20+ cells in TAK patients compared to GCA patients. CD4+CXCR5+ T cells in the aortas of TAK patients had an oligoclonal α/β TCR repertoire.

Conclusion: We established the presence of a specific Tfh cell signature in both circulating and aorta-infiltrating CD4+ T cells from TAK patients. The cooperation of Tfh cells and B cells might be critical in the occurrence of vascular inflammation in patients with TAK.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, CD19 / metabolism
  • Antigens, CD20 / metabolism
  • Aorta
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology*
  • B-Lymphocytes / metabolism
  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism
  • Cell Proliferation
  • Female
  • Gene Expression Profiling
  • Giant Cell Arteritis / genetics
  • Giant Cell Arteritis / immunology*
  • Humans
  • Immunoglobulin G / metabolism
  • Immunologic Memory
  • Immunophenotyping
  • Janus Kinase Inhibitors / pharmacology
  • Male
  • Middle Aged
  • Nitriles
  • Programmed Cell Death 1 Receptor / metabolism
  • Pyrazoles / pharmacology
  • Pyrimidines
  • Receptors, Antigen, T-Cell, alpha-beta / genetics
  • Receptors, CXCR5 / metabolism
  • T Follicular Helper Cells / drug effects
  • T Follicular Helper Cells / immunology*
  • T Follicular Helper Cells / metabolism
  • Takayasu Arteritis / genetics
  • Takayasu Arteritis / immunology*
  • Tertiary Lymphoid Structures / immunology
  • Tertiary Lymphoid Structures / metabolism
  • Tertiary Lymphoid Structures / pathology
  • Transcriptome

Substances

  • Antigens, CD19
  • Antigens, CD20
  • CXCR5 protein, human
  • Immunoglobulin G
  • Janus Kinase Inhibitors
  • Nitriles
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • Pyrazoles
  • Pyrimidines
  • Receptors, Antigen, T-Cell, alpha-beta
  • Receptors, CXCR5
  • ruxolitinib